ALL KEYWORDSRecurrent Cervical CancerRelated SpecialistsShowing 3 of 31Yi AnMDSangini S. ShethMD, MPHShari DamastMDMore Related SpecialistsRelated Fact SheetsCervical DysplasiaRelated Clinical TrialsA Phase II Evaluation of Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2-SN-38 Antibody-drug Conjugate in Patients With Recurrent or Persistent Cervical CancerGynecological CancersRelated DepartmentsShowing 3 of 23Therapeutic RadiologyProstate & Urologic Cancers ProgramGynecologic Oncology ProgramMore Related Departments
